Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMIX NASDAQ:COCH NASDAQ:ICU NYSE:RVP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$1.13+1.4%$1.27$0.96▼$21.49$6.66M-2.97612,261 shs79,490 shsCOCHEnvoy Medical$1.32+2.3%$1.42$1.06▼$3.99$28.41M2.2111,167 shs32,111 shsICUSeaStar Medical$0.84-3.0%$0.77$0.31▼$5.22$23.56M-13.02 million shs897,778 shsRVPRetractable Technologies$0.82-0.5%$0.76$0.56▼$0.93$24.43M1.458,298 shs42,974 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical0.00%-0.48%-1.77%-11.20%-93.23%COCHEnvoy Medical0.00%-2.27%-9.15%-5.84%-60.50%ICUSeaStar Medical0.00%+9.50%+8.26%-20.16%-82.22%RVPRetractable Technologies0.00%+3.76%+3.37%+23.96%-9.67%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$1.13+1.4%$1.27$0.96▼$21.49$6.66M-2.97612,261 shs79,490 shsCOCHEnvoy Medical$1.32+2.3%$1.42$1.06▼$3.99$28.41M2.2111,167 shs32,111 shsICUSeaStar Medical$0.84-3.0%$0.77$0.31▼$5.22$23.56M-13.02 million shs897,778 shsRVPRetractable Technologies$0.82-0.5%$0.76$0.56▼$0.93$24.43M1.458,298 shs42,974 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical0.00%-0.48%-1.77%-11.20%-93.23%COCHEnvoy Medical0.00%-2.27%-9.15%-5.84%-60.50%ICUSeaStar Medical0.00%+9.50%+8.26%-20.16%-82.22%RVPRetractable Technologies0.00%+3.76%+3.37%+23.96%-9.67%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMIXAutonomix Medical 2.50Moderate Buy$5.00348.43% UpsideCOCHEnvoy Medical 3.00Buy$9.25606.11% UpsideICUSeaStar Medical 0.00N/AN/AN/ARVPRetractable Technologies 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest AMIX, COCH, ICU, and RVP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/28/2025AMIXAutonomix MedicalZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMIXAutonomix MedicalN/AN/AN/AN/A$3.29 per shareN/ACOCHEnvoy Medical$220K128.14N/AN/A($0.88) per share-1.49ICUSeaStar Medical$140K175.50N/AN/A($0.34) per share-2.59RVPRetractable Technologies$38.16M0.63$0.02 per share48.25$3.31 per share0.24Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMIXAutonomix Medical-$11.41M-$5.74N/AN/AN/AN/A-172.93%-133.39%11/14/2025 (Estimated)COCHEnvoy Medical-$20.80M-$1.43N/AN/AN/A-10,961.26%N/A-236.14%11/13/2025 (Estimated)ICUSeaStar Medical-$24.83M-$2.62N/A∞N/A-1,915.27%N/A-232.65%11/11/2025 (Estimated)RVPRetractable Technologies-$7.01M-$0.29N/A∞N/A-41.11%-17.15%-9.33%N/ALatest AMIX, COCH, ICU, and RVP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q1 2026AMIXAutonomix Medical-$0.98-$1.07-$0.09-$1.07N/AN/A8/13/2025Q2 2025ICUSeaStar Medical-$0.43-$0.18+$0.25-$0.18$0.25 million$0.34 million7/31/2025Q2 2025COCHEnvoy Medical-$0.29-$0.32-$0.03-$0.32$0.07 million$0.08 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMIXAutonomix MedicalN/AN/AN/AN/AN/ACOCHEnvoy MedicalN/AN/AN/AN/AN/AICUSeaStar MedicalN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMIXAutonomix MedicalN/A4.574.57COCHEnvoy MedicalN/A0.940.74ICUSeaStar MedicalN/A1.521.50RVPRetractable Technologies0.018.575.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMIXAutonomix Medical10.78%COCHEnvoy Medical8.59%ICUSeaStar Medical1.69%RVPRetractable Technologies7.58%Insider OwnershipCompanyInsider OwnershipAMIXAutonomix Medical32.40%COCHEnvoy Medical58.90%ICUSeaStar Medical1.30%RVPRetractable Technologies57.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMIXAutonomix Medical15.92 million4.00 millionN/ACOCHEnvoy Medical3421.52 million8.85 millionNot OptionableICUSeaStar Medical227.92 million27.55 millionNot OptionableRVPRetractable Technologies24029.94 million13.47 millionOptionableAMIX, COCH, ICU, and RVP HeadlinesRecent News About These CompaniesHead-To-Head Contrast: Retractable Technologies (NYSE:RVP) versus Minerva Surgical (NASDAQ:UTRS)September 10, 2025 | americanbankingnews.comRetractable Technologies (NYSE:RVP) vs. Motus GI (NASDAQ:MOTS) Financial ComparisonSeptember 9, 2025 | americanbankingnews.comRetractable Technologies Stock Gains Following Q2 Earnings GrowthAugust 21, 2025 | zacks.comInsider Buying: Retractable Technologies (NYSE:RVP) CEO Acquires 32,935 Shares of StockAugust 20, 2025 | insidertrades.comRetractable Technologies Reports Q2 2025 Financial ResultsAugust 14, 2025 | msn.comRetractable Technologies, Inc. Results for the Periods Ended June 30, 2025August 14, 2025 | businesswire.comRetractable Technologies, Inc. (NYSE:RVP) CEO Purchases $37,155.75 in StockAugust 12, 2025 | insidertrades.comRetractable Technologies, Inc. (NYSE:RVP) CEO Acquires $20,193.12 in StockAugust 1, 2025 | insidertrades.comRetractable Technologies, Inc. Announces Reduction in Its Manufacturing Workforce | RVP Stock NewsJuly 23, 2025 | gurufocus.comRetractable Technologies, Inc. Announces Reduction in Its Manufacturing WorkforceJuly 23, 2025 | businesswire.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders - Business WireJuly 2, 2025 | businesswire.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersJune 30, 2025 | businesswire.comRetractable technologies CEO Shaw buys $14,274 in RVP stockJune 20, 2025 | investing.comZacks Initiates Coverage of Retractable Technologies With Underperform RecommendationJune 19, 2025 | zacks.comRetractable Technologies, Inc. (NYSE:RVP) CEO Buys $14,313.42 in StockJune 19, 2025 | insidertrades.comRetractable Technologies, Inc. (NYSE:RVP) CEO Acquires $13,047.54 in StockJune 17, 2025 | insidertrades.comretractable technologies appoints new auditor after mergerJune 8, 2025 | investing.comThomas J. Shaw Buys 86,014 Shares of Retractable Technologies, Inc. (NYSE:RVP) StockMay 17, 2025 | insidertrades.comRetractable Technologies, Inc. Results for the Period Ended March 31, 2025 | RVP Stock NewsMay 15, 2025 | gurufocus.comRetractable Technologies, Inc. Results for the Period Ended March 31, 2025May 15, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAMIX, COCH, ICU, and RVP Company DescriptionsAutonomix Medical NASDAQ:AMIX$1.12 +0.02 (+1.35%) As of 03:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.Envoy Medical NASDAQ:COCH$1.32 +0.03 (+2.33%) As of 03:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.SeaStar Medical NASDAQ:ICU$0.84 -0.03 (-3.02%) As of 03:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.Retractable Technologies NYSE:RVP$0.82 0.00 (-0.49%) As of 03:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Commercial Growth Story Is Just Getting Started The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Royal Caribbean's 33% Dividend Hike Signals Deeper Growth MarketBeat Week in Review – 09/08 - 09/12 Adobe’s Rebound Has Room to Run: 25% Upside by Year-End Wall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
